Skip to main content
logo
Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
1.270
+0.040 (3.25%)
At close: Aug 21, 2026, 4:00 PM EDT
1.290
+0.020 (1.57%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Actuate Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
30142155--
Market Cap Growth
-80.92%-8.51%---
Enterprise Value
26125142--
Last Close Price
1.276.127.96--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
30.8317.951492.25--
P/TBV Ratio
30.7217.951492.25--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Debt / Equity Ratio
-4.47-1.66-82.940.66-1.31
Quick Ratio
1.162.310.980.434.71
Current Ratio
1.252.391.050.434.71
Return on Equity (ROE)
--553.75%--442.40%-
Return on Assets (ROA)
-213.40%-120.40%-255.41%-132.96%-
Return on Capital Employed (ROCE)
-1490.00%-270.10%-4876.60%636.30%-125.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-67.31%-15.63%-17.55%--
Buyback Yield / Dilution
-32.81%-151.07%-483.48%-18.54%-
SEC Filings: 10-K · 10-Q